RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial

Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial

Add to Collection
RCTs H Singh, B Yadav, AK Rai, S Srivastava… - … Therapies in Medicine, 2023 - Elsevier

Chapter : Section23, Section25
Journal Year : 2023

… state, and old-age individuals are more susceptible to severe COVID-19, whereas young … included in the COVID-19 management protocol by the Indian government for asymptomatic …..... Read More

Keywords : ['openlabel randomize control exploratory trial', 'shunthi zingiber officinale', 'ashwagandha withania somnifera', 'moderate', 'mild']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0965229923000535